Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of the study is to evaluate the efficacy and safety of a treatment regimen of 12 weeks or 8 weeks of simeprevir in combination with sofosbuvir in chronic hepatitis C virus (HCV) genotype 1 infected men and women without cirrhosis who are HCV treatment-naïve or treatment-experienced.
Epistemonikos ID: d142748b132f6b80a2155859baa043cb5efcbde6
First added on: Mar 23, 2020